 |
Diseases |  |
Trials |
|
Trials |  |
News |  |
- | rocakinogene sifuplasmid (INO-9012) / Inovio, INO-3106 / Inovio
Trial completion: Immunotherapy in Subjects With HPV-6 Associated Aerodigestive Precancerous Lesions and Malignancies (clinicaltrials.gov) - Oct 16, 2018
P1, N=3, Completed, Sponsor: Inovio Pharmaceuticals
Active, not recruiting --> Completed
- | rocakinogene sifuplasmid (INO-9012) / Inovio, INO-3106 / Inovio
Enrollment closed, Trial completion date, Trial primary completion date: Immunotherapy in Subjects With HPV-6 Associated Aerodigestive Precancerous Lesions and Malignancies (clinicaltrials.gov) - Jul 26, 2018
P1, N=3, Active, not recruiting, Sponsor: Inovio Pharmaceuticals
Active, not recruiting --> Completed Recruiting --> Active, not recruiting | Trial completion date: Dec 2018 --> Sep 2018 | Trial primary completion date: Jun 2018 --> Sep 2018
- rocakinogene sifuplasmid (INO-9012) / Inovio, INO-3106 / Inovio
Trial primary completion date: Immunotherapy in Subjects With HPV-6 Associated Aerodigestive Precancerous Lesions and Malignancies (clinicaltrials.gov) - Feb 23, 2016
P1, N=6, Recruiting, Sponsor: Inovio Pharmaceuticals
Recruiting --> Active, not recruiting | Trial completion date: Dec 2018 --> Sep 2018 | Trial primary completion date: Jun 2018 --> Sep 2018 Trial primary completion date: Apr 2016 --> Jun 2018
- rocakinogene sifuplasmid (INO-9012) / Inovio, INO-3106 / Inovio
New P1 trial: Immunotherapy in Subjects With HPV-6 Associated Aerodigestive Precancerous Lesions and Malignancies (clinicaltrials.gov) - Sep 16, 2014
P1, N=6, Recruiting, Sponsor: Inovio Pharmaceuticals